Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antithrombotic Regimens in Pregnancies With Mechanical Heart Valves
NCT07658989Recruiting
- Sponsor
- Mount Sinai Hospital
- Start
- May 2026
- Primary completion
- Jan 2030
- Countries
- 1
01
Overview
Open-label trial of low molecular weight heparin calcium, warfarin and aspirin in thrombosis (3 arms), sponsored by Mount Sinai Hospital. Primary endpoints: Adherence rate and Enrollment rate. Started May 2026; status: recruiting.
02
Drugs
low molecular weight heparin calciumwarfarinaspirin
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT07658989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07658989.